```html

Severe Urticaria (Hives)

What is Urticaria (Severe)?

Urticaria, commonly known as “hives,” is a skin reaction that produces erythematous (red), raised, itchy welts called wheals. In its severe form, the welts can be extensive, very painful, and may merge into large plaques that cover large areas of the body. The lesions usually appear suddenly, can change location within minutes to hours, and often last less than 24 hours each, but new lesions keep forming. When the reaction is intense enough to cause significant swelling (angio‑edema), severe discomfort, or threatens breathing, it is considered a medical emergency.

Severe urticaria is classified as either:

• Acute urticaria – lasting < 6 weeks, often triggered by an infection, medication, or food.
• Chronic urticaria – persisting > 6 weeks; can be chronic spontaneous urticaria (CSU) or inducible urticaria (cold, pressure, heat, etc.).

Because the condition reflects an underlying immune or allergic process, understanding the cause is essential for effective management.

Common Causes

Severe urticaria can arise from many triggers. Below are the most frequently reported causes, grouped by category.

• Allergic reactions – foods (nuts, shellfish, eggs), insect stings, latex, or medications (antibiotics, NSAIDs, ACE inhibitors).
• Infections – viral (e.g., hepatitis, EBV, COVID‑19), bacterial (strep throat, Helicobacter pylori), or parasitic (Giardia, helminths).
• Medications – especially penicillins, sulfonamides, contrast dyes, and biologics.
• Physical stimuli – cold, heat, pressure, vibration, sunlight, water (aquagenic urticaria).
• Autoimmune disorders – thyroid disease, systemic lupus erythematosus, rheumatoid arthritis.
• Chronic idiopathic – in up to 50 % of chronic cases, no identifiable trigger is found; autoantibodies against the IgE receptor are suspected.
• Stress & hormonal changes – emotional stress, menstrual cycle, pregnancy.
• Underlying malignancy – rare, but lymphomas and leukemias have been associated with refractory urticaria.
• Dietary additives – food colorings, preservatives, and salicylates.
• Vaccinations – rare but reported after some vaccines, particularly when combined with adjuvants.

Associated Symptoms

Urticaria rarely occurs in isolation. Patients often report one or more of the following:

• Intense itching that worsens with heat or scratching.
• Burning or stinging sensation (especially with angio‑edema).
• Swelling of the lips, eyelids, tongue, or genitals (angio‑edema).
• Difficulty breathing, wheezing, or a tight feeling in the throat – a sign of anaphylaxis.
• Gastrointestinal symptoms – nausea, abdominal cramps, diarrhea.
• Fever, malaise or joint aches when an infection is the trigger.
• Red, watery eyes or nasal congestion if an allergic trigger is involved.

When to See a Doctor

Most cases of urticaria are self‑limited, but you should seek professional care promptly if you notice any of the warning signs below.

• Swelling of the face, lips, tongue, or throat with difficulty swallowing or breathing.
• Persistent wheals lasting more than 24 hours or covering > 30 % of body surface.
• Associated fever, joint pain, or signs of infection.
• Recurrent episodes that last > 6 weeks (chronic urticaria).
• Hives that develop after starting a new medication or after a known allergen exposure.
• Any sign of anaphylaxis (rapid onset, dizziness, fainting, low blood pressure).

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by selective tests to pinpoint the cause.

History

• Onset, duration, and pattern of lesions (daily vs. episodic).
• Recent foods, medications, travel, insect bites, or environmental exposures.
• Family or personal history of allergies, autoimmune disease, or thyroid problems.
• Associated systemic symptoms (fever, joint pain, gastrointestinal upset).

Physical Examination

• Inspection of skin for wheal size, shape, and distribution.
• Assessment for angio‑edema in lips, eyelids, genitalia.
• Vital signs to rule out systemic involvement.

Laboratory & Specialized Tests

• Complete blood count (CBC) & differential – eosinophilia suggests an allergic or parasitic cause.
• Serum tryptase – elevated in mast cell activation (anaphylaxis, mastocytosis).
• Thyroid panel (TSH, free T4, anti‑TPO antibodies) – autoimmune thyroid disease is linked to chronic urticaria.
• IgE levels – high total IgE may support an atopic background.
• Specific IgE or skin prick testing – identifies IgE‑mediated food or inhalant allergies.
• Autoantibody testing (e.g., IgG against FcεRI) – used in specialized centers for chronic spontaneous urticaria.
• Patch testing – if contact dermatitis is suspected.
• Imaging (CXR, ultrasound) – only when systemic disease is suspected.

Treatment Options

Therapy is stepwise, starting with the least invasive measures and escalating based on response.

First‑Line (H₁‑Antihistamines)

• Non‑sedating second‑generation antihistamines (cetirizine, loratadine, fexofenadine, desloratadine) taken at the standard dose.
• If symptoms persist after 48 h, the dose may be increased up to 4‑fold under physician supervision (e.g., cetirizine 40 mg daily).
• Benefits: rapid onset (within 1 hour), minimal sedation, safe for long‑term use.

Second‑Line (Adjunctive Medications)

• H₂‑Antihistamines (ranitidine, famotidine) – add to H₁‑blocker for synergistic effect.
• Leukotriene receptor antagonists (montelukast) – helpful when aspirin/NSAID sensitivity is present.
• Systemic corticosteroids – short courses (e.g., prednisone 0.5 mg/kg for ≤ 7 days) for severe flares or angio‑edema; not suitable for long‑term use due to side effects.

Third‑Line (Targeted Immunomodulators)

• Omalizumab – a monoclonal anti‑IgE antibody; 150–300 mg subcutaneously every 4 weeks. FDA‑approved for chronic spontaneous urticaria refractory to antihistamines.
• Ciclosporin (2–5 mg/kg/day) – reserved for refractory cases; monitor kidney function, blood pressure, and drug levels.
• Other agents under investigation include dupilumab (IL‑4Rα antagonist) and ligelizumab (high‑affinity anti‑IgE).

Home & Lifestyle Measures

• Apply cool compresses to itchy areas for 10–15 minutes.
• Use plain, fragrance‑free moisturizers to protect the skin barrier.
• Avoid hot showers, tight clothing, and known triggers.
• Maintain a symptom diary to identify patterns.
• Stay well hydrated; dehydration can worsen skin itching.

Prevention Tips

While not all episodes are preventable, the following strategies reduce the risk of severe flares:

• Identify and avoid known triggers – keep a food and medication log.
• Wear protective clothing in cold or high‑heat environments if you have physical urticaria.
• Practice good hand hygiene and avoid scratch‑inducing irritants.
• For medication‑related urticaria, discuss alternatives with your prescriber.
• Control underlying thyroid disease or other autoimmune conditions as directed by your specialist.
• Stress‑management techniques (mindfulness, yoga, counseling) can lessen frequency in stress‑sensitive patients.
• If chronic urticaria persists, consider maintenance therapy with a second‑generation antihistamine even when asymptomatic, as recommended by the EAACI/GA²LEN/EDF/WAO guideline.

Emergency Warning Signs

Key Take‑aways

• Severe urticaria presents with large, itchy wheals and can be accompanied by angio‑edema.
• Triggers are diverse—food, drugs, infections, physical stimuli, and autoimmune disease.
• First‑line treatment is a non‑sedating H₁‑antihistamine; escalation to omalizumab or short steroids is common for refractory cases.
• Prompt medical attention is vital for any swelling that threatens the airway or for signs of anaphylaxis.
• Maintaining a trigger diary, using skin‑protective measures, and controlling comorbid conditions are the best preventive strategies.

---

References:

1. Mayo Clinic. “Urticaria (hives).” Accessed July 2026.
2. American Academy of Dermatology. “Urticaria (Hives) Guidelines.” 2023.
3. World Allergy Organization (WAO). “Management of Chronic Spontaneous Urticaria.” 2022.
4. National Institutes of Health (NIH). “Omalizumab for Chronic Idiopathic Urticaria.” ClinicalTrials.gov, 2021.
5. Cleveland Clinic. “Angioedema and Urticaria.” Accessed July 2026.
6. European Academy of Allergy and Clinical Immunology (EAACI). “Guideline for the Management of Urticaria.” 2021.

```